Business Context and Reporting Period
Company: NOVAVAX INC
Filing Type: Form 8-K (Current Report)
Date of Report: February 18, 2003
Event: Completion of a private placement of common stock.
Key Financial Metrics
This filing reports a specific capital raise event rather than periodic financial performance metrics (e.g., revenue, profit, or cash flow from operations). The filing text does not provide a clear value for revenue, profit, margins, or existing debt levels.
| Metric | Value |
|---|---|
| Shares Issued | 4,750,000 |
| Price Per Share | $3.50 |
| Total Proceeds | $16,625,000 |
| Investor | SJ Strategic Investments LLC |
Material Changes
The primary material change is the increase in equity capital and the alteration of shareholder rights agreements:
- Capital Structure: Issuance of 4,750,000 new common shares.
- Shareholder Rights Plan: Provisions waived specifically for SJ Strategic Investments LLC.
- Ownership Limits: A one-year standstill agreement permits SJ Strategic Investments LLC to increase its voting share ownership to 25.0%.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the structural changes to the Stockholder Rights Plan. The transaction was executed via a Common Stock Purchase Agreement dated February 17, 2003.
Investor Verification Checklist
- Verify the updated total share count and diluted ownership percentage following the issuance of 4,750,000 shares.
- Confirm the terms of the one-year standstill agreement and the 25.0% ownership threshold for SJ Strategic Investments LLC.
- Review the attached Press Release (Exhibit 99.1) for details on the intended use of the $16,625,000 in proceeds.
- Check subsequent filings for any further waivers or modifications to the Stockholder Rights Plan.